David M Lang
Affiliation: Cleveland Clinic Foundation
- Omalizumab is efficacious for management of recalcitrant, antihistamine-resistant chronic urticariaD M Lang
Department of Allergy Immunology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA
Drugs Today (Barc) 51:367-74. 2015..Omalizumab is an effective therapeutic option for patients with recalcitrant chronic urticaria. ..
- New asthma guidelines emphasize control, regular monitoringDavid M Lang
Respiratory Institute, Cleveland Clinic Foundation, OH 44195, USA
Cleve Clin J Med 75:641-53. 2008..The revisions in asthma management proposed in these guidelines offer the potential for improved asthma care outcomes in the United States...
- Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?David M Lang
Cleveland Clinic, 9500 Euclid Avenue, Desk C22, Cleveland, OH 44195, USA
Curr Allergy Asthma Rep 8:37-44. 2008....
- An overview of EPR3 asthma guidelines: what's different?David M Lang
Department of Pulmonary, Allergy, and Critical Care, Cleveland Clinic, Cleveland, Ohio 44195, USA
Allergy Asthma Proc 28:620-7. 2007..The revisions in asthma management proposed in these guidelines offer the potential for improved normative care outcomes in asthmatic patients in the United States...
- The long-acting beta-agonist controversy: a clinical dilemmaDavid M Lang
Allergy Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Allergy Asthma Proc 28:136-44. 2007..After the PBL case discussion, a didactic lecture was presented describing the evidence pertaining to the LABA controversy, which is detailed in this article...
- The controversy over long-acting beta agonists: examining the evidenceDavid M Lang
Allergy and Clinical Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, OH 44195, USA
Cleve Clin J Med 73:973-6, 978, 981-4 passim. 2006..As a result, medications that contain salmeterol (Serevent, Advair) or formoterol (Foradil) carry a "black box warning." However, the benefits of these drugs continue to outweigh the risks, if they are used appropriately...
- Hospitalizations for asthma in an urban population: 1995-1999David M Lang
Respiratory Institute, Section of Allergy and Immunology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Ann Allergy Asthma Immunol 103:128-33. 2009..Medications and demographic factors affect asthma hospitalization rates. Recent studies suggest that inhaled long-acting beta-agonists (LABAs) may heighten risk of serious asthma exacerbation, particularly in African Americans...
- Asthma deaths and the athleteDavid M Lang
Allergy and Immunology Section, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA
Clin Rev Allergy Immunol 29:125-9. 2005..Rather, this should reinforce the message that asthma is a condition that may be potentially serious, but can, and should be, well controlled with proper management...
- Glatiramer acetate: successful desensitization for treatment of multiple sclerosisSonia N Bains
Department of Allergy and Immunology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
Ann Allergy Asthma Immunol 104:321-5. 2010..It is also associated with immediate postinjection systemic reactions in approximately 10% of patients. To our knowledge, no desensitization protocols for glatiramer acetate have been published to date...
- The role of allergy evaluation in adults with eosinophilic esophagitisJoshua D Penfield
Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic, Cleveland, Ohio 44195, USA
J Clin Gastroenterol 44:22-7. 2010..Allergy evaluation and skin prick testing for foods are recommended in all patients with eosinophilic esophagitis. However, the yield of allergy evaluation in adult eosinophilic esophagitis is not known...
- Food allergy is associated with potentially fatal childhood asthmaNicola M Vogel
The Children s Hospital, The Cleveland Clinic Foundation, Center for Pediatric Allergy and Immunology, Cleveland, Ohio 44195, USA
J Asthma 45:862-6. 2008..Risk factors for potentially fatal childhood asthma are incompletely understood...
- Allergy diagnostic testing: an updated practice parameterI Leonard Bernstein
University of Cincinnati College of Medicine, Ohio, USA
Ann Allergy Asthma Immunol 100:S1-148. 2008
- Asthma in African Americans: what can we do about the higher rates of disease?Stacy K Silvers
Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA
Cleve Clin J Med 79:193-201. 2012..Further work is needed to better understand these complex risk factors. To remedy these disparities, we need to ensure that patients at higher risk are given proper care and the knowledge to control their asthma...
- Utility of routine laboratory testing in management of chronic urticaria/angioedemaJames A Tarbox
Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Ann Allergy Asthma Immunol 107:239-43. 2011..Laboratory tests are routinely ordered to identify or rule out a cause in patients with chronic urticaria/angioedema (CUA). The results of these tests are usually within normal limits or unremarkable...
- Epidemiology of anaphylaxis at a tertiary care center: A report of 730 casesAlexei Gonzalez-Estrada
Department of Allergy and Immunology, Cleveland Clinic, Cleveland, Ohio Electronic address
Ann Allergy Asthma Immunol 118:80-85. 2017..Recent data reveal that the rate of anaphylaxis is increasing and suggest that idiopathic anaphylaxis may account for most of these cases...
- Diagnostic utility of challenge procedures for physical urticaria/angioedema syndromes: a systematic reviewLyda Cuervo-Pardo
aDepartment of Internal MedicinebDepartment of Allergy and Clinical Immunology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA
Curr Opin Allergy Clin Immunol 16:511-5. 2016..Recent guidelines have recommended use of challenge procedures for diagnosis; however, their positive/negative likelihood ratios have not been established...
- Omalizumab: where does it fit into current asthma management?Todd E Rambasek
Section of Allergy and Immunology, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation, OH 44195, USA
Cleve Clin J Med 71:251-61. 2004..This review discusses how this drug works, which patients will be candidates for it, and the practical aspects of using it...
- Management of group B Streptococcus in pregnant women with penicillin allergyElliot H Philipson
Department of Obstetrics and Gynecology, Hillcrest Hospital, Cleveland Clinic Foundation, 6770 Mayfield Road, Suite 336, Mayfield Heights, OH 44124, USA
J Reprod Med 52:480-4. 2007....
- Blocking aspirin-induced bronchospasmDavid M Lang
Ann Allergy Asthma Immunol 95:307-8. 2005
- Feasibility of a national fatal asthma registry: more evidence of IRB variation in evaluation of a standard protocolSunday Clark
Massachusetts General Hospital, Boston, MA, USA
J Asthma 43:19-23. 2006..The project was revived in 2004 when a standard protocol was submitted to Institutional Review Boards (IRBs) in four different states...
- Stinging insect hypersensitivity: a practice parameter updateJohn E Moffitt
Joint Council of Allergy, Asthma and Immunology, 50 N Brockway St, 3 3, Palatine, IL 60067, USA
J Allergy Clin Immunol 114:869-86. 2004
- Physical activity in urban school-aged children with asthmaDavid M Lang
Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, USA
Pediatrics 113:e341-6. 2004..To compare the physical activity levels of children with and without asthma and evaluate predictors of activity level in children with asthma...
- Evidence-based protocols for oral NSAID challengesDonald D Stevenson
J Pediatr 148:704-5; author reply 705-6. 2006
- The diagnosis and management of rhinitis: an updated practice parameterDana V Wallace
J Allergy Clin Immunol 122:S1-84. 2008